Catherine Caruso is a freelance science journalist based in Boston, Massachusetts. Her work has appeared in Scientific American, MIT Technology Review and Hakai Magazine. She has a master’s degree in zoology from the University of New Hampshire and a master’s degree in science writing from the Massachusetts Institute of Technology.
Catherine Caruso
From this contributor
Diagnostic odyssey; breaking through; leading role
A doctor decodes a rare genetic condition, burnout is a big problem in science, and an actor with autism will play the lead in “The Curious Incident of the Dog in the Night-Time.”
Diagnostic odyssey; breaking through; leading role
By
Catherine Caruso
19 May 2017 | 5 min read
Collaborative conference; drug danger; autism map
Autism researchers and advocates gather in San Francisco, nearly one-third of drugs approved in the United States are later linked to safety issues, and an interactive map lays out locations of U.S. autism clinics.
Collaborative conference; drug danger; autism map
By
Catherine Caruso
12 May 2017 | 4 min read
Network television; facing forward; warm welcome
Researchers captured networks of neurons lighting up in a small aquatic animal, facial recognition software can flag genetic conditions, and a Muppet with autism makes her debut on “Sesame Street.”
Network television; facing forward; warm welcome
By
Catherine Caruso
14 April 2017 | 4 min read
Funding free fall; mending mutations; film focus
Donald Trump’s budget blueprint calls for considerable cuts to science agencies, CRISPR corrects mutations in human embryos, and a documentary highlights the challenges faced by an adult with autism.
Funding free fall; mending mutations; film focus
By
Catherine Caruso
17 March 2017 | 4 min read
Behavior boost; double data; common interests
Neuroscientists should not forget that brains have owners, a new genetic database makes its debut, and the intense interests of people with autism offer opportunities.
Behavior boost; double data; common interests
By
Katie Moisse, Catherine Caruso
3 March 2017 | 4 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read